Trajan Group (TRJ) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
26 Feb, 2026Executive summary
H1 FY26 revenue increased 3.8% year-over-year to $84.1M/AUD 84.1 million, with strong Q2 momentum and growth in Components & Consumables and Disruptive Technologies, but a decline in Capital Equipment revenue.
Normalised EBITDA/NEBITDA was $5.0M, down 36.2% year-over-year, reflecting margin pressures, higher operating expenses, and FX revaluation losses.
Statutory net loss after tax was $0.4M, a significant improvement from a $3.5M loss in the prior year.
The business remains diversified across customer, geography, and product, with a flexible global footprint and strong OEM partnerships.
Strategic investments in inventory and in-region manufacturing impacted Q1 margins but are expected to yield long-term benefits.
Financial highlights
Gross profit rose 1.4% to $29.7M, with group gross margin at 35.3%–37.4%, down 2.3 points year-over-year.
Operating NPATA was $0.8M, down from $1.0M prior year.
Net debt increased by $2.7M to $32.2M, mainly to fund inventory build.
Cash balance at December 2025 was $12.7M, up 6.7% from June 2025; free cash flow was negative at $(1.1)M due to working capital investment.
Inventory peaked at $33.4M in Q2, then reduced to $30M by December, expected to convert to cash in H2.
Outlook and guidance
FY26 guidance reaffirmed: revenue above $170M/AUD 170 million and normalised EBITDA/NEBITDA above $16M.
H2 baseline NEBITDA projected at $8.6M based on Q2 run rate, with further benefits expected from Project Neptune, pricing actions, and supply chain initiatives.
Full-year revenue guidance is $172.6M, with H2 revenue expected at $88.5M.
Inventory investment is expected to convert to cash in H2, supporting improved liquidity.
Management remains confident in guidance, citing strong order book and sales momentum, but notes macroeconomic and currency risks.
Latest events from Trajan Group
- H2 growth, margin recovery, and strong cash flow support a positive FY25 outlook.TRJ
H2 202423 Jan 2026 - All resolutions passed with strong support amid resilient performance and strategic focus.TRJ
AGM 202418 Jan 2026 - Revenue up 6%, EBITDA nearly doubled, and outlook remains strong despite net loss.TRJ
H1 202524 Dec 2025 - Record revenue and EBITDA growth, with strong outlook and improved financial resilience.TRJ
H2 202523 Nov 2025 - Revenue and earnings rose, all resolutions passed, and strategic growth plans advanced.TRJ
AGM 202528 Oct 2025